跳至主要内容
临床试验/CTRI/2017/09/009822
CTRI/2017/09/009822已完成未知

Comparison of efficacy of Tamsulosin vs Tadalafil vs combination of both in lower urinary tract symptoms due to Benign Prostatic Hyperplasia: An Equivalence Randomised Trial

na0 个研究点目标入组 159 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
na
入组人数
159

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. An International Prostatic Symptom Score (IPSS) of >8,
  • 2. maximum urinary flow rate (Qmax) >15 mL/second with minimum voided volume of
  • >125 mL at screening, and
  • 3. willing and able to give written informed consent and comply with study procedures
  • 4. PSA less than 4 ng/ml

排除标准

  • 1. contraindications to investigational drugs including patients with known allergies/allergy
  • to drugs under study,
  • 2. history of syncope, and orthostatic hypotension
  • 3. bladder outlet obstruction due to cancer, calculi or stricture,
  • 4. previous transurethral resection of the prostate,
  • 5. any neurological disorders affecting storage and voiding functions
  • 6. an episode of acute urinary retention within 4 weeks of study initiation,
  • 7. poorly controlled diabetes mellitus

研究者

发起方
na

相似试验